A Ten-Week Online Acceptance and Commitment Therapy Intervention for Family Caregivers of People With Dementia
1 other identifier
interventional
33
1 country
1
Brief Summary
This randomized controlled trial aims to assess the effects of a coach-guided ten-week videoconferencing acceptance and commitment therapy (ACT) program on mental health outcomes in depressed family caregivers of people with dementia (PwD) compared to the control group. A total of 32 family caregivers of PwD who meet the eligibility criteria will be recruited and randomized to either the intervention group or the control group. The hypotheses are that the ACT group will show improvements in depressive symptoms, other mental health outcomes, and ACT process measures at posttest and 3-month follow-up, compared to the control group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 5, 2021
CompletedFirst Posted
Study publicly available on registry
September 14, 2021
CompletedStudy Start
First participant enrolled
March 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 18, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 18, 2024
CompletedOctober 9, 2024
October 1, 2024
2.2 years
September 5, 2021
October 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline to immediately after the intervention and 3 month follow-up on the Patient Health Questionnaire-9
The Patient Health Questionnaire-9 is a 9-item questionnaire assessing depressive symptoms on a scale of 0 to 3. Scores range from 0 to 27. Higher scores indicate greater symptomatology in depression.
Change from baseline to immediately after the intervention and 3 month follow-up
Secondary Outcomes (10)
Change from baseline to immediately after the intervention and 3 month follow-up on the Generalized Anxiety Disorder-7
Change from baseline to immediately after the intervention and 3 month follow-up
Change from baseline to immediately after the intervention and 3 month follow-up on the Perceived Stress Scale
Change from baseline to immediately after the intervention and 3 month follow-up
Change from baseline to immediately after the intervention and 3 month follow-up on the World Health Organization Quality of Life - Psychological health component
Change from baseline to immediately after the intervention and 3 month follow-up
Change from baseline to immediately after the intervention and 3 month follow-up on the Meuser Caregiver Grief Inventory
Change from baseline to immediately after the intervention and 3 month follow-up
Change from baseline to immediately after the intervention and 3 month follow-up on the Caregiver Guilt Questionnaire
Change from baseline to immediately after the intervention and 3 month follow-up
- +5 more secondary outcomes
Study Arms (2)
Acceptance and commitment therapy (ACT) group
EXPERIMENTAL10 weekly ACT sessions individually guided by a trained coach through Zoom videoconferencing with psychoeducation materials provided
Psychoeducation control group
SHAM COMPARATORCare as usual with psychoeducation materials provided
Interventions
Caregivers assigned to this intervention group will receive individual ACT sessions guided by a trained coach for one hour per week over 10 weeks through Zoom videoconferencing with psychoeducation materials provided.
The psychoeducation control group will receive care as usual with psychoeducation materials provided.
Eligibility Criteria
You may qualify if:
- community-dwelling adults (age 18 or over) who are currently taking the primary responsibility for the care of a relative with dementia living in the community
- having at least mild depression as measured by the Patient Health Questionnaire (PHQ)-9
- having a computer or a smartphone with the internet access at home and
- being able to provide informed consent
You may not qualify if:
- having cognitive, physical, or sensory deficits or language barriers (non-English communicator) that impede study participation
- having psychiatric hospitalizations or diagnoses of mental illness in the previous two years
- taking antipsychotic or anticonvulsant medication at the time of recruitment
- considering or planning to place family members of PwD in a nursing home within 6 months or
- having the possibility of study dropouts due to medical conditions of caregivers (e.g., surgery that may affect mental health) and their relatives with dementia (e.g., conditions that may impede study participation due to frequent hospitalization or death)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Alabama at Birminghamlead
- Alzheimer's Associationcollaborator
Study Sites (1)
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
Related Publications (1)
Han A, Oster R, Yuen H, Jenkins J, Hawkins J, Edwards L. Videoconference-Delivered Acceptance and Commitment Therapy for Family Caregivers of People With Dementia: Pilot Randomized Controlled Trial. JMIR Form Res. 2025 Mar 31;9:e67545. doi: 10.2196/67545.
PMID: 40163859DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Areum Han, PhD
University of Alabama at Birmingham
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
September 5, 2021
First Posted
September 14, 2021
Study Start
March 21, 2022
Primary Completion
June 18, 2024
Study Completion
June 18, 2024
Last Updated
October 9, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share